Gilder Gagnon Howe & Co’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-567,469	Closed	-$9.62M	–	300
2014 Q4	$9.62M	Sell	567,469 -106,176	-16%	-$1.49M	0.14%	101
2014 Q3	$8.03M	Buy	+673,645	New	+$4.6M	0.12%	112

Gilder Gagnon Howe & Co's AVNR Position: Q1 2015 in Review

Gilder Gagnon Howe & Co sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 567,469 shares — an estimated $9.62M sold.

Gilder Gagnon Howe & Co first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $9.62M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Gilder Gagnon Howe & Co reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 567,469 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $9.62M.
Gilder Gagnon Howe & Co first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
Gilder Gagnon Howe & Co's AVANIR PHARMACEUTICALS, INC CL A position peaked at $9.62M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2015, filed 30 Apr 2015.